COMMUNIQUÉS West-GlobeNewswire

-
US FDA removes REMS requirement for TRYVIO (aprocitentan) – minimizing the burden on the healthcare delivery systems and patients
17/03/2025 -
Roche to share latest scientific advancements from its neuromuscular portfolio at Muscular Dystrophy Association (MDA) 2025 conference
17/03/2025 -
Global Reach for US Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites
17/03/2025 -
Dyne Therapeutics Announces New Long-Term Clinical Data from Phase 1/2 DELIVER Trial of DYNE-251 in Duchenne Muscular Dystrophy Demonstrating Unprecedented and Sustained Functional Improvement Through 18 Months
17/03/2025 -
DentPure Under Review: How Probiotics Help Support Stronger Teeth & Healthier Gums
16/03/2025 -
Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRαME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025
15/03/2025 -
Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer
15/03/2025 -
ProDentim Under Review: Why Taking Probiotics for Stronger Teeth & Healthier Gums is Trending
15/03/2025 -
Cannabix Technologies announces Stock Option Grant and Director Resignation
14/03/2025 -
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
14/03/2025 -
Arch Biopartners Closes Non-Brokered Private Placement
14/03/2025 -
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price Requirement
14/03/2025 -
Pacira BioSciences Confirms Receipt of Director Nominations from DOMA Perpetual
14/03/2025 -
Kestra Medical Technologies, Ltd. Announces Full Exercise and Closing of Underwriters' Over-Allotment Option in Initial Public Offering
14/03/2025 -
ExoPTEN Preclinical Study Demonstrates Significant Potential for Enhancing Motor Function, Blood Flow, and Spinal Cord Injury Recovery
14/03/2025 -
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14/03/2025 -
Fifty 1 Labs, Inc. Completes Name and Symbol Change, Advances Toward Regaining 15c211 Compliance
14/03/2025 -
Blue Antioxidant: How Prime Biome Restores Skin with 10x Retinol Strength
14/03/2025 -
Notice to Convene Annual General Meeting 2025 - Item 6: Election of members to the Board of Directors
14/03/2025
Pages